---
title: "14:23 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--ESI, CRNX, SOLS, and PATK"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292939529.md"
description: "Monteverde & Associates PC is launching a legal inquiry into potential class action lawsuits regarding four mergers and acquisitions: Element Solutions (ESI) merging with Solstice Advanced Materials, Crinetics Pharmaceuticals (CRNX) being sold to Vertex, Solstice Advanced Materials (SOLS), and Patrick Industries (PATK) merging with LCI Industries. The firm invites shareholders of these companies to contact them for more information."
datetime: "2026-07-16T18:25:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292939529.md)
  - [en](https://longbridge.com/en/news/292939529.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292939529.md)
---

# 14:23 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--ESI, CRNX, SOLS, and PATK

, /PRNewswire/ -- **Class Action Attorney** Juan Monteverde **with** Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a **Top 50 Firm** in the 2025 ISS Securities Class Action Services Report. We are headquartered at the **Empire State Building** in New York City and are investigating

-   **Element Solutions, Inc. (NYSE:** **ESI****)** related to its sale to Solstice Advanced Materials, Inc. Under the terms of the proposed transaction, Element Solutions shareholders will receive $10.00 in cash and 0.500 shares of Solstice common stock for each Element Solutions share. Upon closing of the proposed transaction, Element Solutions shareholders are expected to own approximately 44% of the combined company.

**Click here for more info** **https://monteverdelaw.com/case/element-solutions-inc/****.** **It is free and there is no cost or obligation to you.**

-   **Crinetics Pharmaceuticals, Inc. (NASDAQ:** **CRNX****)** related to its sale to Vertex Pharmaceuticals Incorporated. Under the terms of the proposed transaction, Crinetics shareholders are expected to receive $85.00 per share in cash.

**Click here for more information** **https://monteverdelaw.com/case/crinetics-pharmaceuticals-inc/****.** **It is free and there is no cost or obligation to you.**

-   **Solstice Advanced Materials, Inc. (NASDAQ:** **SOLS****)** related to its merger with Element Solutions, Inc.

**Click here for more information** **https://monteverdelaw.com/case/solstice-advanced-materials-inc**/**.** **It is free and there is no cost or obligation to you.**

-   **Patrick Industries, Inc. (NASDAQ:** **PATK****)** related to its merger with LCI Industries. Upon completion of the proposed transaction, Patrick shareholders will own approximately 52% of the combined company.

**Click here for more info** **https://monteverdelaw.com/case/patrick-industries-inc/****.** **It is free and there is no cost or obligation to you.**

**NOT ALL LAW FIRMS ARE THE SAME.** Before you hire a law firm, you should talk to a lawyer and ask:

1.  Do you file class actions and go to Court?
2.  When was the last time you recovered money for shareholders?
3.  What cases did you recover money in and how much?

**About Monteverde & Associates PC**

Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.

**No company, director or officer is above the law.** If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our **website** or contact Juan Monteverde, Esq. either via e-mail at **\[email protected\]** or by telephone at (212) 971-1341.

Contact:  
Juan Monteverde, Esq.  
MONTEVERDE & ASSOCIATES PC  
**The Empire State Building  
**350 Fifth Ave. Suite 4740  
New York, NY 10118  
United States of America  
\[email protected\]  
Tel: (212) 971-1341

Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE Monteverde & Associates PC

### Related Stocks

- [CRNX.US](https://longbridge.com/en/quote/CRNX.US.md)
- [SOLS.US](https://longbridge.com/en/quote/SOLS.US.md)
- [PATK.US](https://longbridge.com/en/quote/PATK.US.md)
- [ESI.US](https://longbridge.com/en/quote/ESI.US.md)
- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)
- [LCII.US](https://longbridge.com/en/quote/LCII.US.md)
- [SOLSV.US](https://longbridge.com/en/quote/SOLSV.US.md)

## Related News & Research

- [Solstice Advanced Materials amends credit agreement to allow $4.69 billion bridge financing](https://longbridge.com/en/news/293937229.md)
- [ESI: Record Q2 2026 revenue and EBITDA driven by Electronics and semiconductor strength](https://longbridge.com/en/news/293971579.md)
- [Solstice to Acquire Element Solutions; Forecasts $180M+ Synergies, $6.8B Pro Forma Revenue](https://longbridge.com/en/news/293214963.md)
- [Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by PNC Financial Services Group Inc.](https://longbridge.com/en/news/293817909.md)
- [CRNX: Pipeline advances in acromegaly, CAH, and NETs, with strong financial runway into 2030](https://longbridge.com/en/news/293389069.md)